Samuel Agresta - Net Worth and Insider Trading
Samuel Agresta Net Worth
The estimated net worth of Samuel Agresta is at least $0 dollars as of 2024-11-29. Samuel Agresta is the Chief Medical Officer of Foghorn Therapeutics Inc and owns about 0 shares of Foghorn Therapeutics Inc (FHTX) stock worth over $0. Details can be seen in Samuel Agresta's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Samuel Agresta has not made any transactions after 2023-08-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Samuel Agresta
Samuel Agresta Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Samuel Agresta owns 2 companies in total, including Foghorn Therapeutics Inc (FHTX) , and Infinity Pharmaceuticals Inc (INFIQ) .
Click here to see the complete history of Samuel Agresta’s form 4 insider trades.
Insider Ownership Summary of Samuel Agresta
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FHTX | Foghorn Therapeutics Inc | 2023-08-16 | Chief Medical Officer |
| INFIQ | Infinity Pharmaceuticals Inc | 2018-08-06 | Chief Medical Officer |
Samuel Agresta Latest Holdings Summary
Samuel Agresta currently owns a total of 1 stock. Samuel Agresta owns 0 shares of Foghorn Therapeutics Inc (FHTX) as of August 16, 2023, with a value of $0.
Latest Holdings of Samuel Agresta
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FHTX | Foghorn Therapeutics Inc | 2023-08-16 | 0 | 7.79 | 0 |
Holding Weightings of Samuel Agresta
Samuel Agresta Form 4 Trading Tracker
According to the SEC Form 4 filings, Samuel Agresta has made a total of 1 transactions in Foghorn Therapeutics Inc (FHTX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Foghorn Therapeutics Inc is the sale of 311,297 shares on August 16, 2023, which brought Samuel Agresta around $3 Million.
Insider Trading History of Samuel Agresta
- 1
Samuel Agresta Trading Performance
Samuel Agresta Ownership Network
Samuel Agresta Owned Company Details
What does Foghorn Therapeutics Inc do?
Who are the key executives at Foghorn Therapeutics Inc?
Samuel Agresta is the Chief Medical Officer of Foghorn Therapeutics Inc. Other key executives at Foghorn Therapeutics Inc include Chief People Officer Carlos Costa , See Remarks Steven F. Bellon , and Chief Strategy/Bus Ops Officer Fanny Cavalie .
Foghorn Therapeutics Inc (FHTX) Insider Trades Summary
Over the past 18 months, Samuel Agresta made 1 insider transaction in Foghorn Therapeutics Inc (FHTX) with a net sale of 311,297. Other recent insider transactions involving Foghorn Therapeutics Inc (FHTX) include a net sale of 58,859 shares made by Carlos Costa , a net sale of 20,000 shares made by Steven F. Bellon , and a net sale of 11,000 shares made by Fanny Cavalie .
In summary, during the past 3 months, insiders sold 78,859 shares of Foghorn Therapeutics Inc (FHTX) in total and bought 0 shares, with a net sale of 78,859 shares. During the past 18 months, 401,156 shares of Foghorn Therapeutics Inc (FHTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 401,156 shares.
Foghorn Therapeutics Inc (FHTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Foghorn Therapeutics Inc Insider Transactions
Samuel Agresta Mailing Address
Above is the net worth, insider trading, and ownership report for Samuel Agresta. You might contact Samuel Agresta via mailing address: 784 Memorial Dr., Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
